A unique clone involving multiple structural chromosome rearrangements in a myelodysplastic syndrome case

Cancer Genetics and Cytogenetics

Volumn 140, Issue 2, 2003, Pages 138-144

  Yan, Ju ^a,b   Whittom, Renaud ^a   Delage, Robert ^b   Drouin, Régen ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE;

ADULT; ARTICLE; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; BRAIN HEMORRHAGE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CASE REPORT; CAUSE OF DEATH; CHROMOSOME G BAND; CHROMOSOME REARRANGEMENT; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; KARYOTYPE 46,XX; KARYOTYPING; MOLECULAR CLONING; MYELODYSPLASTIC SYNDROME; PARENCHYMA; PRIMED IN SITU LABELING; PRIORITY JOURNAL; PROGNOSIS; SIDEROBLASTIC ANEMIA; STRUCTURAL CHROMOSOME ABERRATION;

ADULT; ANEMIA, REFRACTORY; BLAST CRISIS; BONE MARROW; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 20; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 5; CLONE CELLS; DISEASE PROGRESSION; FATAL OUTCOME; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOCYTIC, ACUTE; PROGNOSIS; RING CHROMOSOMES; TRANSLOCATION, GENETIC;

EID: 0037438879     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00682-9     Document Type: Article

References (31)

1. Boultwood J., Fidler C. Chromosomal deletions in myelodysplasia. Leuk Lymphoma. 17:1995;71-78.
2. Lowenthal R.M., Marsden K.A. Myelodysplastic syndromes. Int J Hematol. 65:1997;319-338.
3. Mitelman F., Mertens F., Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet. 15:1997;417-474.
4. Mecucci C., Van den Berghe H. Myelodysplastic syndromes. cytogenetics Haematol Oncol Clin North Am. 6:1992;523-538.
5. Kurtin P.J., Dewald G.W., Shields D.J., Hanson C.A. Hematologic disorders associated with deletions of chromosome 20q. a clinicopathologic study of 107 patients Am J Clin Pathol. 106:1996;680-688.
6. Asimakopoulos F.A., Green A.R. Deletions of chromosome 20q and the pathogenesis of myeloproliferative disorders. Br J Haematol. 95:1996;219-226.
7. Yunis J.J., Rydell R.E., Oken M.M., Arnesen M.A., Mayer M.G., Lobell M. Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. Blood. 67:1986;1721-1730.
8. Parlier V., van Melle G., Beris P., Schmidt P.M., Tobler A., Haller E., Bellomo M.J. Hematologic, clinical, and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome. Prognostic significance of morphology and chromosome findings. Cancer Genet Cytogenet. 78:1994;219-231.
9. Sole F., Prieto F., Badia L., Woessner S., Florensa L., Caballin M.R., Coll M.D., Besses C., Sans-Sabrafen J. Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes. Cancer Genet Cytogenet. 64:1992;12-20.
10. Greenberg P., Cox C., LeBeau M.M., Fenaux P., Morel P., Sanz G., Sanz M., Vallespi T., Hamblin T., Oscier D., Ohyashiki K., Toyama K., Aul C., Mufti G., Bennett J. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 89:1997;2079-2088. [published erratum appears in Blood 1998;91(3):1100].
11. Musilova J., Michalova K., Zemanova Z., Neuwirthova R., Dohnalova A. Karyotype at diagnosis, subsequent leukemic transformation and survival in myelodysplastic syndrome. Czechoslovak MDS Cooperative Group. Leuk Res. 19:1995;303-308.
12. Haase D., Fonatsch C., Freund M., Wormann B., Bodenstein H., Bartels H., Stollmann-Gibbels B., Lengfelder E. Cytogenetic findings in 179 patients with myelodysplastic syndromes. Ann Hematol. 70:1995;171-187.
13. Yoshida A., Ueda T., Imamura S., Uchida M., Kamada N., Nakamura T. Two types of ring chromosomes found in a patient with myelodysplastic syndrome. Leukemia. 7:1993;1921-1923.
14. Xu J., Cedrone E., Roberts M., Wu G., Gershagen S., Wang N. The characterization of chromosomal rearrangements by a combined micro- FISH approach in a patient with myelodysplastic syndrome. Cancer Genet Cytogenet. 83:1995;105-110.
15. Gray J.W., Pinkel D., Brown J.M. Fluorescence in situ hybridization in cancer and radiation biology. Radiat Res. 137:1994;275-289.
16. Lemieux N., Drouin R., Richer C.-L. High-resolution dynamic and morphological G-bandings (GBG and GTG). a comparative study Hum Genet. 85:1990;261-266.
17. Seabright M. A rapid banding technique for human chromosomes. Lancet. 2:1971;971-972.
18. Therkelsen A.J., Nielsen A., Koch J., Hindkjaer J., Kolvraa S. Staining of human telomeres with primed in situ labeling (PRINS). Cytogenet Cell Genet. 68:1995;115-118.
19. Mitelman F. An international system for human cytogenetic nomenclature. 1995;S. Karger, Basel.
20. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 51:1982;189-199.
21. Deiss A. Acquired disorders associated with hematologic malignancies. Lee G.R., Bithell T.C., Foerster J., Athens J.W., Lukens J.N. Wintrobe's clinical hematology. 1993;1949-1959 Lea & Febiger, London.
22. Van den Berghe H., Michaux L. 5q-, twenty-five years later. a synopsis Cancer Genet Cytogenet. 94:1997;1-7.
23. Nagarajan L. Molecular analysis of the 5q- chromosome. Leuk Lymphoma. 17:1995;361-366.
24. Masey J.A. The myelodysplastic syndromes. Br J Biomed Sci. 54:1997;65-70.
25. Nagarajan L., Zhao L., Lu X., Warrington J.A., Wasmuth J.J., Siciliano M., Deisseroth A.B., Liang J.C. 5q- chromosome. Evidence for complex interstitial breaks in a case of refractory anemia with excess blasts. Cancer Genet Cytogenet. 74:1994;8-12.
26. Tefferi A., Mathew P., Noel P. The 5q- syndrome. a scientific and clinical update Leuk Lymphoma. 14:1994;375-378.
27. Cortes J., O'Brien S., Kantarjian H., Cork A., Stass S., Freireich E.J., Keating M., Pierce S., Estey E. Abnormalities in the long arm of chromosome 11 (11q) in patients with de novo and secondary acute myelogenous leukemias and myelodysplastic syndromes. Leukemia. 8:1994;2174-2178.
28. Taki T., Sako M., Tsuchida M., Hayashi Y. The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. Blood. 89:1997;3945-3950.
29. Najfeld V., Chen A., Scalise A., Ambinder E.P., Fernandez G., Waxman S. Myelodysplastic syndrome transforming to acute promyelocytic-like leukemia with trisomy and rearrangement of chromosome 11. Genes Chromosomes Cancer. 10:1994;15-25.
30. Preudhomme C., Vachee A., Lepelley P., Vanrumbeke M., Zandecki M., Quesnel B., Cosson A., Fenaux P. Inactivation of the retinoblastoma gene appears to be very uncommon in myelodysplastic syndromes. Br J Haematol. 87:1994;61-67.
31. Jacobs R.H., Cornbleet M.A., Vardiman J.W., Larson R.A., Le Beau M.M., Rowley J.D. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood. 67:1986;1765-1772.